Tubize-Fin (TUB) - Net Assets
Based on the latest financial reports, Tubize-Fin (TUB) has net assets worth €1.89 Billion EUR (≈ $2.20 Billion USD) as of December 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (€1.93 Billion ≈ $2.26 Billion USD) and total liabilities (€48.58 Million ≈ $56.79 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check Tubize-Fin liquidity resilience to evaluate the company's liquid asset resilience ratio.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | €1.89 Billion |
| % of Total Assets | 97.49% |
| Annual Growth Rate | 5.96% |
| 5-Year Change | -41.93% |
| 10-Year Change | -3.68% |
| Growth Volatility | 17.86 |
Tubize-Fin - Net Assets Trend (2000–2025)
This chart illustrates how Tubize-Fin's net assets have evolved over time, based on quarterly financial data. Also explore total assets of Tubize-Fin for the complete picture of this company's asset base.
Annual Net Assets for Tubize-Fin (2000–2025)
The table below shows the annual net assets of Tubize-Fin from 2000 to 2025. For live valuation and market cap data, see TUB market cap.
| Year | Net Assets | Change |
|---|---|---|
| 2025-12-31 | €1.89 Billion ≈ $2.20 Billion |
+2.45% |
| 2024-12-31 | €1.84 Billion ≈ $2.15 Billion |
+2.44% |
| 2023-12-31 | €1.80 Billion ≈ $2.10 Billion |
+2.57% |
| 2022-12-31 | €1.75 Billion ≈ $2.05 Billion |
-46.05% |
| 2021-12-31 | €3.25 Billion ≈ $3.80 Billion |
+16.25% |
| 2020-12-31 | €2.79 Billion ≈ $3.27 Billion |
+4.83% |
| 2019-12-31 | €2.66 Billion ≈ $3.11 Billion |
+13.88% |
| 2018-12-31 | €2.34 Billion ≈ $2.74 Billion |
+10.58% |
| 2017-12-31 | €2.12 Billion ≈ $2.47 Billion |
+8.08% |
| 2016-12-31 | €1.96 Billion ≈ $2.29 Billion |
+0.53% |
| 2015-12-31 | €1.95 Billion ≈ $2.28 Billion |
+20.07% |
| 2014-12-31 | €1.62 Billion ≈ $1.90 Billion |
+4.54% |
| 2013-12-31 | €1.55 Billion ≈ $1.81 Billion |
+3.96% |
| 2012-12-31 | €1.49 Billion ≈ $1.74 Billion |
-3.61% |
| 2011-12-31 | €1.55 Billion ≈ $1.81 Billion |
+7.23% |
| 2010-12-31 | €1.44 Billion ≈ $1.69 Billion |
+6.40% |
| 2009-12-31 | €1.36 Billion ≈ $1.59 Billion |
+13.53% |
| 2008-12-31 | €1.20 Billion ≈ $1.40 Billion |
-5.22% |
| 2007-12-31 | €1.26 Billion ≈ $1.47 Billion |
-6.93% |
| 2006-12-31 | €1.36 Billion ≈ $1.58 Billion |
+50.33% |
| 2005-12-31 | €901.39 Million ≈ $1.05 Billion |
+52.12% |
| 2004-12-31 | €592.56 Million ≈ $692.76 Million |
-6.67% |
| 2003-12-31 | €634.91 Million ≈ $742.27 Million |
+10.10% |
| 2002-12-31 | €576.65 Million ≈ $674.17 Million |
+11.23% |
| 2001-12-31 | €518.43 Million ≈ $606.10 Million |
+16.91% |
| 2000-12-31 | €443.43 Million ≈ $518.42 Million |
-- |
Equity Component Analysis
This analysis shows how different components contribute to Tubize-Fin's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 18020523600.0% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (December 2025)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | €180.21 Million | 9.56% |
| Common Stock | €235.00 Million | 12.46% |
| Other Comprehensive Income | €1.47 Billion | 77.91% |
| Other Components | €1.22 Million | 0.06% |
| Total Equity | €1.89 Billion | 100.00% |
Tubize-Fin Competitors by Market Cap
The table below lists competitors of Tubize-Fin ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
News Corp A
NASDAQ:NWSA
|
$9.90 Billion |
|
Jinduicheng Molybdenum Co Ltd
SHG:601958
|
$9.90 Billion |
|
Antero Midstream Partners LP
NYSE:AM
|
$9.90 Billion |
|
Shanghai International Airport Co Ltd
SHG:600009
|
$9.90 Billion |
|
Viavi Solutions Inc
NASDAQ:VIAV
|
$9.89 Billion |
|
Beijing Kunlun Tech Co Ltd
SHE:300418
|
$9.89 Billion |
|
Gotion High tech Co Ltd
SHE:002074
|
$9.88 Billion |
|
Smithfield Foods, Inc. Common Stock
NASDAQ:SFD
|
$9.88 Billion |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Tubize-Fin's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from 1,840,405,526 to 1,885,559,936, a change of 45,154,410 (2.5%).
- Net income of 93,228,016 contributed positively to equity growth.
- Dividend payments of 46,315,000 reduced retained earnings.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | €93.23 Million | +4.94% |
| Dividends Paid | €46.31 Million | -2.46% |
| Other Changes | €-1.76 Million | -0.09% |
| Total Change | €- | 2.45% |
Book Value vs Market Value Analysis
This analysis compares Tubize-Fin's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 4.73x
- The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
- The price-to-book ratio has decreased from 25.68x to 4.73x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2003-12-31 | €7.80 | €200.40 | x |
| 2004-12-31 | €13.02 | €200.40 | x |
| 2005-12-31 | €20.21 | €200.40 | x |
| 2006-12-31 | €30.38 | €200.40 | x |
| 2007-12-31 | €28.27 | €200.40 | x |
| 2008-12-31 | €26.80 | €200.40 | x |
| 2009-12-31 | €30.42 | €200.40 | x |
| 2010-12-31 | €32.37 | €200.40 | x |
| 2011-12-31 | €34.71 | €200.40 | x |
| 2012-12-31 | €33.46 | €200.40 | x |
| 2013-12-31 | €34.78 | €200.40 | x |
| 2014-12-31 | €36.25 | €200.40 | x |
| 2015-12-31 | €43.71 | €200.40 | x |
| 2016-12-31 | €43.97 | €200.40 | x |
| 2017-12-31 | €47.50 | €200.40 | x |
| 2018-12-31 | €52.52 | €200.40 | x |
| 2019-12-31 | €418.02 | €200.40 | x |
| 2020-12-31 | €62.74 | €200.40 | x |
| 2021-12-31 | €72.94 | €200.40 | x |
| 2022-12-31 | €39.35 | €200.40 | x |
| 2023-12-31 | €40.36 | €200.40 | x |
| 2024-12-31 | €41.35 | €200.40 | x |
| 2025-12-31 | €42.36 | €200.40 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Tubize-Fin utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 4.94%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 0.00%
- • Asset Turnover: 0.00x
- • Equity Multiplier: 1.03x
- Recent ROE (4.94%) is below the historical average (11.60%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2003 | 47.23% | 54422.12% | 0.00x | 3.16x | €93.09 Million |
| 2004 | 20.91% | 6195350.00% | 0.00x | 1.21x | €64.65 Million |
| 2005 | 32.60% | 96.36% | 0.30x | 1.13x | €203.72 Million |
| 2006 | 35.22% | 303.77% | 0.10x | 1.18x | €341.77 Million |
| 2007 | 3.13% | 67.48% | 0.03x | 1.33x | €-86.58 Million |
| 2008 | -0.08% | -5.70% | 0.01x | 1.33x | €-120.44 Million |
| 2009 | 12.03% | 90.97% | 0.10x | 1.27x | €27.60 Million |
| 2010 | 1.45% | 55.99% | 0.02x | 1.24x | €-123.53 Million |
| 2011 | 4.18% | 76.35% | 0.05x | 1.21x | €-90.15 Million |
| 2012 | 5.21% | 83.87% | 0.05x | 1.20x | €-71.43 Million |
| 2013 | 3.98% | 81.40% | 0.04x | 1.16x | €-93.44 Million |
| 2014 | 3.75% | 84.99% | 0.04x | 1.13x | €-101.34 Million |
| 2015 | 10.91% | 21252600.00% | 0.00x | 1.16x | €17.79 Million |
| 2016 | 9.26% | 59995.36% | 0.00x | 1.14x | €-14.57 Million |
| 2017 | 13.52% | 105.03% | 0.12x | 1.09x | €74.37 Million |
| 2018 | 12.19% | 98.93% | 0.12x | 1.06x | €51.20 Million |
| 2019 | 10.65% | 9456800.00% | 0.00x | 1.03x | €17.27 Million |
| 2020 | 9.33% | 0.00% | 0.00x | 1.01x | €-18.77 Million |
| 2021 | 11.71% | 0.00% | 0.00x | 1.01x | €55.41 Million |
| 2022 | 4.86% | 1044901.09% | 0.00x | 1.05x | €-89.99 Million |
| 2023 | 4.91% | 0.00% | 0.00x | 1.07x | €-91.51 Million |
| 2024 | 4.90% | 679673.60% | 0.00x | 1.05x | €-93.94 Million |
| 2025 | 4.94% | 0.00% | 0.00x | 1.03x | €-95.33 Million |
Industry Comparison
This section compares Tubize-Fin's net assets metrics with peer companies in the Biotechnology industry.
Industry Context
- Industry: Biotechnology
- Average net assets among peers: $732,069,496
- Average return on equity (ROE) among peers: -22.60%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Tubize-Fin (TUB) | €1.89 Billion | 47.23% | 0.03x | $9.89 Billion |
| Argen-X (ARGX) | $10.23 Million | 0.00% | 0.20x | $42.08 Billion |
| BioSenic S.A. (BIOS) | $-6.76 Million | 0.00% | 0.00x | $1.57 Million |
| Celyad SA (CYAD) | $90.88 Million | -25.97% | 0.53x | $8.95 Million |
| Hyloris Developmentsen Sa (HYL) | $39.07 Million | -39.37% | 0.22x | $168.91 Million |
| Onward Medical N.V. (ONWD) | $52.63 Million | -62.27% | 0.46x | $184.65 Million |
| Oxurion NV (OXUR) | $48.44 Million | -32.97% | 0.07x | $311.42K |
| UCB SA (UCB) | $4.89 Billion | 2.35% | 1.08x | $51.74 Billion |
About Tubize-Fin
Financière de Tubize SA operates as a mono holding company whose sole investment is a stake in UCB which is a biopharma company in Belgium. It engages in discovering and developing treatments for patients suffering from serious illnesses that affect the immune system or the central nervous system. The company was incorporated in 1928 and is based in Brussels, Belgium.